Cadence Neuroscience

Headquarter
Redmond, WA - United States

Milestones
Founded: 2017
Invested: 2023

Founders / CEO
Kent Leyde, CEO

Vertical
Biotech / Connected Health Devices

Board Participation
Thomas Thestrup, Board Member

Website

Linkedin

 

 

Developer of an implantable therapy device designed to improve treatment methods for people suffering from neurological disorders like epilepsy. The company's devices offer therapies that detect specific signals from the brain and deliver electrical stimulation to modify the activity of neural circuits, enabling patients suffering from neurological problems to be adequately addressed with available treatment options.

 

Related news:

Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy